Dr. Flavia Matovu Kiweewa
HIV Prevention & Maternal Health Specialist
Makerere University / Global Health Programmes
Championing Equity and Leadership in HIV: Dr. Flavia Matovu Kiweewa at the PAHCS Launch
The participation of Dr. Flavia Matovu Kiweewa at the launch of the Pan-African HIV Clinicians Society (PAHCS) brings a powerful and often underrepresented dimension to the HIV response, leadership that is inclusive, community-informed, and deeply rooted in equity.
Dr. Kiweewa is widely recognised for her work at the intersection of HIV prevention, maternal and adolescent health, and implementation science. Her career has focused on ensuring that HIV programmes are not only scientifically sound, but also responsive to the lived realities of women, young people, and vulnerable populations. This is increasingly critical as Africa’s HIV response faces new pressures, including funding constraints and widening inequalities that disproportionately affect these groups.
Her work aligns closely with a growing global understanding: ending HIV requires more than biomedical innovation, it demands inclusive leadership and systems that reflect the needs of those most affected. Through her involvement with leadership platforms such as WomenLift Health, Dr. Kiweewa has been part of a broader movement to elevate women into decision-making roles in global health, an area where disparities remain significant.
At PAHCS, her presence reinforces a key pillar of the organisation’s vision—building a truly representative, pan-African clinical voice. While scientific advances such as long-acting therapies and emerging cure research continue to evolve, their success will depend on equitable access, community trust, and culturally relevant implementation. Dr. Kiweewa brings precisely this lens.
Her contribution is expected to shape how PAHCS approaches prevention strategies, particularly among high-risk populations such as adolescent girls and young women, who continue to account for a disproportionate share of new infections in parts of Africa. She also strengthens the society’s focus on integrating gender, policy, and clinical care,ensuring that innovation reaches those who need it most.
As PAHCS positions itself as a continental leader in HIV care, Dr. Kiweewa’s involvement signals a commitment not only to scientific excellence, but to equity, representation, and sustainable impact. Her voice ensures that Africa’s HIV response remains grounded in people, not just programmes, an essential ingredient in ultimately ending the epidemic.
The participation of Dr. Flavia Matovu Kiweewa at the launch of the Pan-African HIV Clinicians Society (PAHCS) brings a powerful and often underrepresented dimension to the HIV response, leadership that is inclusive, community-informed, and deeply rooted in equity.
Dr. Kiweewa is widely recognised for her work at the intersection of HIV prevention, maternal and adolescent health, and implementation science. Her career has focused on ensuring that HIV programmes are not only scientifically sound, but also responsive to the lived realities of women, young people, and vulnerable populations. This is increasingly critical as Africa’s HIV response faces new pressures, including funding constraints and widening inequalities that disproportionately affect these groups.
Her work aligns closely with a growing global understanding: ending HIV requires more than biomedical innovation, it demands inclusive leadership and systems that reflect the needs of those most affected. Through her involvement with leadership platforms such as WomenLift Health, Dr. Kiweewa has been part of a broader movement to elevate women into decision-making roles in global health, an area where disparities remain significant.
At PAHCS, her presence reinforces a key pillar of the organisation’s vision—building a truly representative, pan-African clinical voice. While scientific advances such as long-acting therapies and emerging cure research continue to evolve, their success will depend on equitable access, community trust, and culturally relevant implementation. Dr. Kiweewa brings precisely this lens.
Her contribution is expected to shape how PAHCS approaches prevention strategies, particularly among high-risk populations such as adolescent girls and young women, who continue to account for a disproportionate share of new infections in parts of Africa. She also strengthens the society’s focus on integrating gender, policy, and clinical care,ensuring that innovation reaches those who need it most.
As PAHCS positions itself as a continental leader in HIV care, Dr. Kiweewa’s involvement signals a commitment not only to scientific excellence, but to equity, representation, and sustainable impact. Her voice ensures that Africa’s HIV response remains grounded in people, not just programmes, an essential ingredient in ultimately ending the epidemic.
